| Ralph Clement Darling Iii, MD | |
|
391 Myrtle Ave, Suite 5, The Vascular Group, Pllc, Albany, NY 12208-3412 | |
| (518) 262-5640 | |
| (518) 262-9413 |
| Full Name | Ralph Clement Darling Iii |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 40 Years |
| Location | 391 Myrtle Ave, Suite 5, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174513956 | NPI | - | NPPES |
| 01240028 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Albany Medical Center Hospital | Albany, NY | Hospital |
| St Mary's Healthcare | Amsterdam, NY | Hospital |
| Saratoga Hospital | Saratoga springs, NY | Hospital |
| Faxton-st Luke's Healthcare | Utica, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Medical College | 1759293111 | 910 |
News Archive
Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent "circling the lot" and unable to cause pain, swelling and possible joint damage.
Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.
A medical team has developed a way to effectively provide a large group of people with basic knowledge and skills to locate and use bleeding control equipment to stop life-threatening bleeding in severely injured people.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
› Verified 4 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent "circling the lot" and unable to cause pain, swelling and possible joint damage.
Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.
A medical team has developed a way to effectively provide a large group of people with basic knowledge and skills to locate and use bleeding control equipment to stop life-threatening bleeding in severely injured people.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
› Verified 4 days ago
| Entity Name | The Vascular Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124018478 PECOS PAC ID: 2365436649 Enrollment ID: O20040409000569 |
News Archive
Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent "circling the lot" and unable to cause pain, swelling and possible joint damage.
Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.
A medical team has developed a way to effectively provide a large group of people with basic knowledge and skills to locate and use bleeding control equipment to stop life-threatening bleeding in severely injured people.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
› Verified 4 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891277000 PECOS PAC ID: 1759293111 Enrollment ID: O20190102000038 |
News Archive
Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent "circling the lot" and unable to cause pain, swelling and possible joint damage.
Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.
A medical team has developed a way to effectively provide a large group of people with basic knowledge and skills to locate and use bleeding control equipment to stop life-threatening bleeding in severely injured people.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
› Verified 4 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent "circling the lot" and unable to cause pain, swelling and possible joint damage.
Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.
A medical team has developed a way to effectively provide a large group of people with basic knowledge and skills to locate and use bleeding control equipment to stop life-threatening bleeding in severely injured people.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ralph Clement Darling Iii, MD 391 Myrtle Ave, Suite 5, The Vascular Group, Pllc, Albany, NY 12208-3797 Ph: (518) 262-5640 | Ralph Clement Darling Iii, MD 391 Myrtle Ave, Suite 5, The Vascular Group, Pllc, Albany, NY 12208-3412 Ph: (518) 262-5640 |
News Archive
Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent "circling the lot" and unable to cause pain, swelling and possible joint damage.
Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.
A medical team has developed a way to effectively provide a large group of people with basic knowledge and skills to locate and use bleeding control equipment to stop life-threatening bleeding in severely injured people.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
› Verified 4 days ago
Dr. Todd Beyer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. Carl Rosati, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Adriana Laser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave Ste 5, Albany, NY 12208 Phone: 518-262-5640 | |
Dr. John B Waldman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5088 Fax: 518-262-5400 | |
Dr. Andrew L Isenberg, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 304, Albany, NY 12208 Phone: 518-525-5206 | |
Dr. Edward Choongho Lee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. Elizabeth Robison, MD Surgery Medicare: Medicare Enrolled Practice Location: 113 Holland Ave, Mail Code 112, Albany, NY 12208 Phone: 518-626-6588 Fax: 518-626-6606 |